Altered immune proteome of Staphylococcus aureus under iron-restricted growth conditions

Proteomics

Volumn 14, Issue 16, 2014, Pages 1857-1867

  Stentzel, Sebastian ^a   Vu, Hai Chi ^a   Weyrich, Anna Maria ^a   Jehmlich, Nico ^a   Schmidt, Frank ^a   Salazar, Manuela Gesell ^a   Steil, Leif ^a   Völker, Uwe ^a   Bröker, Barbara M ^a  

^a UNIVERSITY MEDICINE GREIFSWALD   (Germany)

Author keywords

Antibody; Iron restriction; Microbiology; Secretome; Staphylococcus aureus; Stress adaptation

Indexed keywords

IMMUNOGLOBULIN G; PROTEOME; BACTERIAL PROTEIN; BACTERIUM ANTIBODY; IRON; HEMOLYSIN; SUPERANTIGEN;

ANTIBODY RESPONSE; ANTIBODY SPECIFICITY; ARTICLE; BACTERIAL GROWTH; CELL PROLIFERATION; GROWTH INHIBITION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IRON RESTRICTION; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEOMICS; SEQUENCE ANALYSIS; STAPHYLOCOCCUS AUREUS; ADULT; FEMALE; GROWTH, DEVELOPMENT AND AGING; HOST PATHOGEN INTERACTION; IMMUNOLOGY; MALE; METABOLISM; MICROBIOLOGY; MIDDLE AGED; PHYSIOLOGY; STAPHYLOCOCCUS INFECTION; YOUNG ADULT; ADAPTATION; ANTIBODY BLOOD LEVEL; ANTIGEN BINDING; BACTERIUM CULTURE; BINDING AFFINITY; CONTROLLED STUDY; IMMUNOGLOBULIN BLOOD LEVEL; MICROENVIRONMENT; MITOGENICITY; PROTEIN SECRETION; SUPERNATANT;

ADULT; ANTIBODIES, BACTERIAL; BACTERIAL PROTEINS; FEMALE; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNOGLOBULIN G; IRON; MALE; MIDDLE AGED; PROTEOMICS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; YOUNG ADULT;

EID: 84905674579     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.201300512     Document Type: Article

References (58)

1. Goss, C. H., Muhlebach, M. S., Review: Staphylococcus aureus and MRSA in cystic fibrosis. J. Cyst. Fibros 2011, 10, 298-306.
2. van Belkum, A., Verkaik, N. J., de Vogel, C. P., Boelens, H. A. et al., Reclassification of Staphylococcus aureus nasal carriage types. J. Infect. Dis. 2009, 199, 1820-1826.
3. Gamblin, J., Jefferies, J. M., Harris, S., Ahmad, N. et al., Nasal self-swabbing for estimating the prevalence of Staphylococcus aureus in the community. J. Med. Microbiol. 2013, 62, 437-440.
4. Rigby, K. M., DeLeo, F. R., Neutrophils in innate host defense against Staphylococcus aureus infections. Semin. Immunopathol. 2012, 34, 237-259.
5. Foster, T. J., Immune evasion by staphylococci. Nat. Rev. Microbiol. 2005, 3, 948-958.
6. Sibbald, M. J., Ziebandt, A. K., Engelmann, S., Hecker, M. et al., Mapping the pathways to staphylococcal pathogenesis by comparative secretomics. Microbiol. Mol. Biol. Rev. 2006, 70, 755-788.
7. Ziebandt, A. K., Kusch, H., Degner, M., Jaglitz, S. et al., Proteomics uncovers extreme heterogeneity in the Staphylococcus aureus exoproteome due to genomic plasticity and variant gene regulation. Proteomics 2010, 10, 1634-1644.
8. Dreisbach, A., van Dijl, J. M., Buist, G., The cell surface proteome of Staphylococcus aureus. Proteomics 2011, 11, 3154-3168.
9. Cassat, J. E., Skaar, E. P., Metal ion acquisition in Staphylococcus aureus: overcoming nutritional immunity. Semin. Immunopathol. 2012, 34, 215-235.
10. Diekema, D. J., Pfaller, M. A., Schmitz, F. J., Smayevsky, J. et al., Survey of infections due to Staphylococcus species: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe, and the Western Pacific region for the SENTRY Antimicrobial Surveillance Program, 1997-1999. Clin. Infect. Dis. 2001, 32(Suppl 2), S114-S132.
11. Noskin, G. A., Rubin, R. J., Schentag, J. J., Kluytmans, J. et al., National trends in Staphylococcus aureus infection rates: impact on economic burden and mortality over a 6-year period (1998-2003). Clin. Infect. Dis. 2007, 45, 1132-1140.
12. Robinson, D. A., Enright, M. C., Multilocus sequence typing and the evolution of methicillin-resistant Staphylococcus aureus. Clin. Microbiol. Infect. 2004, 10, 92-97.
13. Lo, W. T., Wang, C. C., Panton-Valentine leukocidin in the pathogenesis of community-associated methicillin-resistant Staphylococcus aureus infection. Pediatr. Neonatol. 2011, 52, 59-65.
14. Krishna, S., Miller, L. S., Host-pathogen interactions between the skin and Staphylococcus aureus. Curr. Opin. Microbiol. 2012, 15, 28-35.
15. Liebeke, M., Dorries, K., Zuhlke, D., Bernhardt, J. et al., A metabolomics and proteomics study of the adaptation of Staphylococcus aureus to glucose starvation. Mol. Biosyst. 2011, 7, 1241-1253.
16. Hecker, M., Becher, D., Fuchs, S., Engelmann, S., A proteomic view of cell physiology and virulence of Staphylococcus aureus. Int. J. Med. Microbiol. 2010, 300, 76-87.
17. Fuchs, S., Pane-Farre, J., Kohler, C., Hecker, M., Engelmann, S., Anaerobic gene expression in Staphylococcus aureus. J. Bacteriol. 2007, 189, 4275-4289.
18. Hammer, N. D., Skaar, E. P., Molecular mechanisms of Staphylococcus aureus iron acquisition. Annu. Rev. Microbiol. 2011, 65, 129-147.
19. Haley, K. P., Skaar, E. P., A battle for iron: host sequestration and Staphylococcus aureus acquisition. Microbes Infect. 2012, 14, 217-227.
20. DeDent, A., Kim, H. K., Missiakas, D., Schneewind, O., Exploring Staphylococcus aureus pathways to disease for vaccine development. Semin. Immunopathol. 2012, 34, 317-333.
21. Grigg, J. C., Ukpabi, G., Gaudin, C. F., Murphy, M. E., Structural biology of heme binding in the Staphylococcus aureus Isd system. J. Inorg. Biochem. 2010, 104, 341-348.
22. Broker, B. M., van Belkum, A., Immune proteomics of Staphylococcus aureus. Proteomics 2011, 11, 3221-3231.
23. Cheung, A. L., Koomey, J. M., Butler, C. A., Projan, S. J., Fischetti, V. A., Regulation of exoprotein expression in Staphylococcus aureus by a locus (sar) distinct from agr. Proc. Natl. Acad. Sci. USA 1992, 89, 6462-6466.
24. Holtfreter, S., Nguyen, T. T., Wertheim, H., Steil, L. et al., Human immune proteome in experimental colonization with Staphylococcus aureus. Clin. Vaccine Immunol. 2009, 16, 1607-1614.
25. Kolata, J., Bode, L. G., Holtfreter, S., Steil, L. et al., Distinctive patterns in the human antibody response to Staphylococcus aureus bacteremia in carriers and non-carriers. Proteomics 2011, 11, 3914-3927.
26. Eymann, C., Dreisbach, A., Albrecht, D., Bernhardt, J. et al., A comprehensive proteome map of growing Bacillus subtilis cells. Proteomics 2004, 4, 2849-2876.
27. Karanam, N. K., Grabarczyk, P., Hammer, E., Scharf, C. et al., Proteome analysis reveals new mechanisms of Bcl11b-loss driven apoptosis. J. Proteome Res. 2010, 9, 3799-3811.
28. Fuchs, S., Mehlan, H., Kusch, H., Teumer, A. et al., Protecs, a comprehensive and powerful storage and analysis system for OMICS data, applied for profiling the anaerobiosis response of Staphylococcus aureus COL. Proteomics 2010, 10, 2982-3000.
29. Pfortner, H., Wagner, J., Surmann, K., Hildebrandt, P. et al., A proteomics workflow for quantitative and time-resolved analysis of adaptation reactions of internalized bacteria. Methods 2013, 61, 244-250.
30. Feig, M. A., Hammer, E., Volker, U., Jehmlich, N., In-depth proteomic analysis of the human cerumen-a potential novel diagnostically relevant biofluid. J. Proteomics 2013, 83, 119-129.
31. Silva, J. C., Gorenstein, M. V., Li, G. Z., Vissers, J. P., Geromanos, S. J., Absolute quantification of proteins by LCMSE: a virtue of parallel MS acquisition. Mol. Cell. Proteomics 2006, 5, 144-156.
32. Petersen, T. N., Brunak, S., von Heijne, G., Nielsen, H., SignalP 4.0: discriminating signal peptides from transmembrane regions. Nat. Methods 2011, 8, 785-786.
33. Holtfreter, S., Bauer, K., Thomas, D., Feig, C. et al., egc-Encoded superantigens from Staphylococcus aureus are neutralized by human sera much less efficiently than are classical staphylococcal enterotoxins or toxic shock syndrome toxin. Infect. Immun. 2004, 72, 4061-4071.
34. Holtfreter, S., Kolata, J., Broker, B. M., Towards the immune proteome of Staphylococcus aureus-the anti-S. aureus antibody response. Int. J. Med. Microbiol. 2010, 300, 176-192.
35. Dryla, A., Prustomersky, S., Gelbmann, D., Hanner, M. et al., Comparison of antibody repertoires against Staphylococcus aureus in healthy individuals and in acutely infected patients. Clin. Diagn. Lab. Immunol. 2005, 12, 387-398.
36. Vandenesch, F., Lina, G., Henry, T., Staphylococcus aureus hemolysins, bi-component leukocidins, and cytolytic peptides: a redundant arsenal of membrane-damaging virulence factors? Front. Cell. Infect. Microbiol. 2012, 2, 12.
37. Holtfreter, S., Broker, B. M., Staphylococcal superantigens: do they play a role in sepsis? Arch. Immunol. Ther. Exp. (Warsz) 2005, 53, 13-27.
38. Grumann, D., Nubel, U., Broker, B. M., Staphylococcus aureus toxins-their functions and genetics. Infect. Genet. Evol. 2014, 21, 583-592.
39. Fraser, J. D., Proft, T., The bacterial superantigen and superantigen-like proteins. Immunol. Rev. 2008, 225, 226-243.
40. Grumann, D., Scharf, S. S., Holtfreter, S., Kohler, C. et al., Immune cell activation by enterotoxin gene cluster (egc)-encoded and non-egc superantigens from Staphylococcus aureus. J. Immunol. 2008, 181, 5054-5061.
41. Vytvytska, O., Nagy, E., Bluggel, M., Meyer, H. et al., Identification of vaccine candidate antigens of Staphylococcus aureus by serological proteome analysis. Proteomics 2002, 2, 580-590.
42. Lorenz, U., Ohlsen, K., Karch, H., Hecker, M. et al., Human antibody response during sepsis against targets expressed by methicillin resistant Staphylococcus aureus. FEMS Immunol. Med. Microbiol. 2000, 29, 145-153.
43. Le Marechal, C., Jan, G., Even, S., McCulloch, J. A. et al., Development of serological proteome analysis of mastitis by Staphylococcus aureus in ewes. J. Microbiol. Methods 2009, 79, 131-136.
44. Kim, H. K., DeDent, A., Cheng, A. G., McAdow, M. et al., IsdA and IsdB antibodies protect mice against Staphylococcus aureus abscess formation and lethal challenge. Vaccine 2010, 28, 6382-6392.
45. Kuklin, N. A., Clark, D. J., Secore, S., Cook, J. et al., A novel Staphylococcus aureus vaccine: iron surface determinant B induces rapid antibody responses in rhesus macaques and specific increased survival in a murine S. aureus sepsis model. Infect. Immun. 2006, 74, 2215-2223.
46. Fowler, V. G., Allen, K. B., Moreira, E. D., Moustafa, M. et al., Effect of an investigational vaccine for preventing Staphylococcus aureus infections after cardiothoracic surgery: a randomized trial. JAMA 2013, 309, 1368-1378.
47. Biswas, L., Biswas, R., Nerz, C., Ohlsen, K. et al., Role of the twin-arginine translocation pathway in Staphylococcus. J. Bacteriol. 2009, 191, 5921-5929.
48. Allard, M., Moisan, H., Brouillette, E., Gervais, A. L. et al., Transcriptional modulation of some Staphylococcus aureus iron-regulated genes during growth in vitro and in a tissue cage model in vivo. Microbes Infect. 2006, 8, 1679-1690.
49. den Reijer, P. M., Lemmens-den Toom, N., Kant, S., Snijders, S. V. et al., Characterization of the humoral immune response during Staphylococcus aureus bacteremia and global gene expression by Staphylococcus aureus in human blood. PLoS One 2013, 8, e53391.
50. van der Kooi-Pol, M. M., de Vogel, C. P., Westerhout-Pluister, G. N., Veenstra-Kyuchukova, Y. K. et al., High anti-staphylococcal antibody titers in patients with epidermolysis bullosa relate to long-term colonization with alternating types of Staphylococcus aureus. J. Invest. Dermatol. 2013, 133, 847-850.
51. Verkaik, N. J., Lebon, A., de Vogel, C. P., Hooijkaas, H. et al., Induction of antibodies by Staphylococcus aureus nasal colonization in young children. Clin. Microbiol. Infect. 2010, 16, 1312-1317.
52. Verkaik, N. J., de Vogel, C. P., Boelens, H. A., Grumann, D. et al., Anti-staphylococcal humoral immune response in persistent nasal carriers and noncarriers of Staphylococcus aureus. J. Infect. Dis. 2009, 199, 625-632.
53. Holtfreter, S., Jursa-Kulesza, J., Masiuk, H., Verkaik, N. J. et al., Antibody responses in furunculosis patients vaccinated with autologous formalin-killed Staphylococcus aureus. Eur. J. Clin. Microbiol. Infect. Dis. 2011, 30, 707-717.
54. Beasley, F. C., Vines, E. D., Grigg, J. C., Zheng, Q. et al., Characterization of staphyloferrin A biosynthetic and transport mutants in Staphylococcus aureus. Mol. Microbiol. 2009, 72, 947-963.
55. Sebulsky, M. T., Heinrichs, D. E., Identification and characterization of fhuD1 and fhuD2, two genes involved in iron-hydroxamate uptake in Staphylococcus aureus. J. Bacteriol. 2001, 183, 4994-5000.
56. Miethke, M., Monteferrante, C. G., Marahiel, M. A., van Dijl, J. M., The Bacillus subtilis EfeUOB transporter is essential for high-affinity acquisition of ferrous and ferric iron. Biochim. Biophys. Acta 2013, 1833, 2267-2278.
57. Speziali, C. D., Dale, S. E., Henderson, J. A., Vines, E. D., Heinrichs, D. E., Requirement of Staphylococcus aureus ATP-binding cassette-ATPase FhuC for iron-restricted growth and evidence that it functions with more than one iron transporter. J. Bacteriol. 2006, 188, 2048-2055.
58. Beasley, F. C., Marolda, C. L., Cheung, J., Buac, S., Heinrichs, D. E., Staphylococcus aureus transporters Hts, Sir, and Sst capture iron liberated from human transferrin by Staphyloferrin A, Staphyloferrin B, and catecholamine stress hormones, respectively, and contribute to virulence. Infect. Immun. 2011, 79, 2345-2355.